Pfizer Form 20-F, March 30, 2022, for (FYE Dec 31, 2021)

Pfizer warns investors that risks exist that could prevent them from receiving regulatory approval in the US, UK, EU and elsewhere

D. Risk Factors (page 6 & 7)

• We may not be able to demonstrate sufficient efficacy or safety of our COVID-19 vaccine and/or variant-specific formulations to obtain permanent regulatory approval in the United States, the United Kingdom, the European Union, or other countries

• Significant adverse events may occur during our clinical trials or even after receiving regulatory approval, which could delay or terminate clinical trials, delay or prevent regulatory approval

• Even if we obtain full regulatory approval for our COVID-19 vaccine and product candidates, the products may not gain the market acceptance

Risks Related to our COVID-19 vaccine and the Commercialization of our Pipeline (pg. 8)

• the durability of immune response generated by our COVID-19 vaccine, which has not yet been demonstrated in clinical trials

• our ability to receive full regulatory approvals, where we currently have emergency use authorizations or equivalents;

https://investors.biontech.de/node/11931/html#ic5e06a05a31d4c4491031d3208cef8c2_2806

Wha wha wha whaaa Whaaat?

I thought these things were "approved" last year?

Is this Dean Wormer with a new "double secret approval"?